Loading…
Safer Compounding in Hospitals Act of 2024
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
87pct
186d open
vs 10,564 other HR bills in the 118th — cohort avg 68d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2024 · fourth_quarter · Pharmacy
Issues related to implementation of the Drug Quality and Security Act, issues related to animal drug compounding, issues relating to opioid safety; issues related to the pharmaceutical supply chain; issues related to drug shortages; H.R. 167, the Patient Access to Urgent Use Pharmacy Compounding Act of 2023; patient access to compounded medications; H.R. 3810 - Drug Origin Transparency Act of 2023; H.R. 8749, Safer Compounding in Hospitals Act
Client expense: $100,000 · Firm income: Not reported
Referred to the Subcommittee on Health.
Referred to the House Committee on Ways and Means.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · fourth_quarter · Medicare/Medicaid
Issues pertaining to the Medicare programs treatment of automated drug compounding technology (Safer Compounding in Hospitals Act (HR 8749)
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Pharmacy
Issues related to implementation of the Drug Quality and Security Act, issues related to animal drug compounding, issues relating to opioid safety; issues related to the pharmaceutical supply chain; issues related to drug shortages; H.R. 167, the Patient Access to Urgent Use Pharmacy Compounding Act of 2023; patient access to compounded medications; H.R. 3810 - Drug Origin Transparency Act of 2023; H.R. 8749, Safer Compounding in Hospitals Act
Client expense: $120,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · third_quarter · Medicare/Medicaid
IIssues pertaining to the Medicare programs treatment of automated drug compounding technology (Safer Compounding in Hospitals Act (HR 8749)
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Medicare/Medicaid
IIssues pertaining to the Medicare programs treatment of automated drug compounding technology (Safer Compounding in Hospitals Act (HR 8749)
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE